FDA Announces Plan To Bring Clinical Trial Monitoring Up To Date
This article was originally published in The Gray Sheet
Executive Summary
FDA hopes a new initiative will help its oversight system catch up to an increasingly complex clinical trial environment characterized by electronic records, subcontracting and growing fraud concerns